Novo CEO pressed by Senate to chop costs of weight problems, diabetes prescription drugs CEO Lars Fruergaard Jørgensen informed lawmakers the organization would take into consideration new talks with insurers about the list costs of Wegovy and copyright if they pledge to keep the medicines on their own formularies. The https://dave-s-hot-chicken-nutrit53197.wizzardsblog.com/30610263/healthcare-news-an-overview